<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain>AIMS/HYPOTHESIS: Central <z:hpo ids='HP_0001513'>obesity</z:hpo>, <z:hpo ids='HP_0000855'>insulin resistance</z:hpo> and <z:hpo ids='HP_0006279'>beta cell dysfunction</z:hpo> are independent risk factors for incident type 2 <z:mp ids='MP_0002055'>diabetes</z:mp>, although few studies have used detailed measures of these disorders </plain></SENT>
<SENT sid="1" pm="."><plain>Our objective was to study the association of directly measured visceral and subcutaneous adipose tissue (VAT, SAT), insulin sensitivity (S (I)) and the <z:hpo ids='HP_0011009'>acute</z:hpo> insulin response (AIR) with incident type 2 <z:mp ids='MP_0002055'>diabetes</z:mp> </plain></SENT>
<SENT sid="2" pm="."><plain>METHODS: Participants were 1,230 Hispanic-Americans and African-Americans in the <z:hpo ids='HP_0000855'>Insulin Resistance</z:hpo> <z:hpo ids='HP_0002621'>Atherosclerosis</z:hpo> Study (IRAS) Family Study who were free of type 2 <z:mp ids='MP_0002055'>diabetes</z:mp> at baseline (2000-2002) </plain></SENT>
<SENT sid="3" pm="."><plain>S (I) and AIR were determined from frequently sampled IVGTTs with minimal model analysis </plain></SENT>
<SENT sid="4" pm="."><plain>VAT and SAT were determined by computed tomography </plain></SENT>
<SENT sid="5" pm="."><plain>Impaired fasting <z:chebi fb="105" ids="17234">glucose</z:chebi> and type 2 <z:mp ids='MP_0002055'>diabetes</z:mp> were defined according to American <z:mp ids='MP_0002055'>Diabetes</z:mp> Association criteria </plain></SENT>
<SENT sid="6" pm="."><plain>RESULTS: Incident type 2 <z:mp ids='MP_0002055'>diabetes</z:mp> was diagnosed in 90 participants after 5 years </plain></SENT>
<SENT sid="7" pm="."><plain>After adjustment for age, sex, ethnicity, centre, impaired fasting <z:chebi fb="105" ids="17234">glucose</z:chebi>, triacylglycerol, <z:chebi fb="4" ids="47775">HDL-cholesterol</z:chebi> and systolic BP, both S(I) and AIR were inversely associated with type 2 <z:mp ids='MP_0002055'>diabetes</z:mp> (S (I), OR 0.53, 95% CI 0.39-0.73; AIR, OR 0.22, 95% CI 0.14-0.34 per SD; both p &lt; 0.001), while both VAT and SAT were positively associated with type 2 <z:mp ids='MP_0002055'>diabetes</z:mp> (VAT, OR 1.68, 95% CI 1.22-2.33; SAT, OR 1.49, 95% CI 1.13-1.99; both p &lt; 0.01) </plain></SENT>
<SENT sid="8" pm="."><plain>In a model including <z:hpo ids='HP_0000001'>all</z:hpo> four factors, S (I) and AIR (S (I), OR 0.55, 95% CI 0.37-0.80; AIR, OR 0.21, 95% CI 0.13-0.33; both p &lt; 0.01) were significant predictors of type 2 <z:mp ids='MP_0002055'>diabetes</z:mp>, although associations with VAT and SAT were no longer significant </plain></SENT>
<SENT sid="9" pm="."><plain>A significant sex x VAT interaction indicated a stronger association of VAT with type 2 <z:mp ids='MP_0002055'>diabetes</z:mp> in women than in men </plain></SENT>
<SENT sid="10" pm="."><plain>CONCLUSIONS/INTERPRETATION: <z:hpo ids='HP_0000855'>Insulin resistance</z:hpo>, <z:hpo ids='HP_0006279'>beta cell dysfunction</z:hpo> and VAT predicted incident type 2 <z:mp ids='MP_0002055'>diabetes</z:mp>, with evidence of a stronger association of VAT with type 2 <z:mp ids='MP_0002055'>diabetes</z:mp> among women </plain></SENT>
</text></document>